To investigate (1) whether type 3 17b-hydroxysteroid dehydrogenase (17b-HSD), the enzyme which catalyzes the conversion of androstenedione to testosterone in the testis, is co-expressed with P450aromatase in the preadipocytes of women, and (2) whether the relative expression of type 3 17b-HSD and aromatase varies in subcutaneous abdominal vs intra-abdominal adipose tissue of women. SUBJECTS: Subcutaneous abdominal and intra-abdominal adipose tissue was obtained from women undergoing elective abdominal surgery (age 22 -78 y, body mass index (BMI) 22.4 -52.9 kg=m 2 ). MEASUREMENTS: Expression of type 3 17b-HSD in adipose cell fractions was determined using RT-PCR. Preadipocyte steroidogenesis was investigated in primary cultures using androstenedione as substrate. Messenger RNA levels for type 3 17b-HSD and aromatase were measured in adipose tissue from the subcutaneous abdominal and intra-abdominal depots using a quantitative multiplex competitive RT-PCR assay. RESULTS: Type 3 17b-HSD is co-expressed with aromatase in the abdominal preadipocytes of women. Cultured preadipocytes from both subcutaneous abdominal (n ¼ 5) and intra-abdominal (n ¼ 5) sites converted androstenedione to testosterone, and there was minimal conversion of androstenedione to estrone. Consistent with this, the levels of type 3 17b-HSD mRNA were significantly higher than aromatase mRNA at both sites (P < 0.05; n ¼ 8 subcutaneous abdominal, n ¼ 12 intra-abdominal adipose tissue). The ratio of levels of 17b-HSD mRNA to aromatase mRNA in intra-abdominal adipose tissue was positively correlated with BMI (n ¼ 11, r ¼ 0.61, P < 0.05) and waist circumference (n ¼ 10, r ¼ 0.65, P < 0.05). The converse was found in subcutaneous abdominal adipose tissue. CONCLUSION: The intra-abdominal adipose tissue of women may be substantially androgenic, increasingly so with increasing obesity, particularly central obesity. While androgen production by this adipose tissue deposit may not contribute to circulating testosterone levels due to hepatic clearance, it may have hitherto unrecognised local effects in the intra-abdominal adipose tissue and also on the liver via the hepatic portal system. These studies suggest a mechanism linking central obesity with insulin resistance and dyslipidaemia.
Introduction
Peripheral tissues are important sites of sex steroid hormone biosynthesis in women. Conversion of androstenedione in peripheral tissues accounts for approximately 50% of the testosterone production in normal premenopausal women 1, 2 and 100% of estrogen production in postmenopausal women. 3 These conversions, catalysed by 17b-hydroxysteroid dehydrogenase (17b-HSD) and cytochrome P450 arom (aromatase) respectively, have been demonstrated to occur in adipose tissue. 4, 5 In adipose tissue, aromatase activity and mRNA is localised predominantly in preadipocytes. 5, 6 Killinger et al 7 reported that there are regional differences in preadipocyte sex steroid production. In cultured preadipocytes derived from human subcutaneous abdominal and omental adipose tissue, the formation of androgens from androstenedione was 10-fold greater than the formation of estrone, whereas in adipose tissue from the buttock and thigh, the production of androgens and estrone from androstenedione was equivalent. 7 Consistent with this, aromatase mRNA levels were higher in the buttocks than in subcutaneous abdominal adipose tissue of women. 8 These data suggest that there are regional variations in the level of expression of aromatase and 17b-HSD in the adipose tissue of women.
The regulation of aromatase expression in adipose tissue has been extensively investigated. 9 In contrast, very few studies have examined the cellular localisation and control of 17b-HSD expression in adipose tissue. Several 17b-HSD enzymes involved in sex steroid synthesis or inactivation have now been characterised in the human. 10 -16 These vary in subcellular localisation and tissue expression, steroid substrate and cofactor affinity, and in their preference for catalysing oxidative or reductive reactions. Type 3 17b-HSD preferentially converts androstenedione to testosterone and is expressed in testis.
14 It is also expressed in adipose tissue 17 and may be responsible for androgenic 17b-HSD activity in the adipose tissue of women. In this study our aims unfolded stepwise. We first demonstrated that preadipocytes expressed type 3 17b-HSD in addition to aromatase. We then showed that cultured preadipocytes from the subcutaneous abdominal and intraabdominal adipose tissue of women produced testosterone, and to a lesser extent, estrone from androstenedione. These results suggested that within preadipocytes, the relative levels of expression of type 3 17b-HSD and aromatase determine whether androstenedione is preferentially converted to androgen or estrogen. We therefore established a quantitative multiplex competitive reverse-transcription polymerase chain reaction (RT-PCR) assay to measure the ratios of the mRNAs encoding type 3 17b-HSD and aromatase and then examined this ratio in subcutaneous abdominal and intraabdominal adipose tissue of women with a range of body mass indices.
Materials and methods
Patient selection and adipose tissue sample collection The study was approved by the Committee for Clinical Investigations at Flinders Medical Centre and the subjects gave written informed consent. Subcutaneous abdominal and intra-abdominal adipose tissue samples were collected from women aged 22 -78 y undergoing elective laparotomy. Premenopausal women reported regular menstrual cycles. Women taking the oral contraceptive pill, hormonal replacement therapy or other medications known to affect adipose tissue metabolism, such as corticosteroids, during the prior 3 months were excluded. Testes from prostate carcinoma patients undergoing bilateral orchidectomy and human term placenta were also obtained.
Adipose tissue samples for quantitative RT-PCR assay (15 subjects) were immediately frozen in liquid nitrogen and stored at 7 70 C until RNA extraction. BMI of these subjects ranged from 22.4 to 52.9 kg=m 2 (mean 34 AE s.d. 8.5 kg=m 2 ). Waist circumference 18 ranged from 71 to 148 cm (mean 102 AE s.d. 20.2 cm). No data on height, weight or waist circumference were available from one subject and waist circumference of a further subject was not available.
Isolation of adipose cell fractions
Adipose tissue samples for localisation of type 3 17b-HSD expression (two subjects) and preadipocyte primary culture (five subjects) were separated into stromal cell and mature adipocyte fractions using the technique of Rodbell. 19 Cell fractions for analysis of expression of type 3 17b-HSD and aromatase using RT-PCR were stored at 7 70 C for subsequent RNA extraction. An aliquot of each of the cell fractions was examined by light microscopy: the cell types were distinguished on the basis of their morphology and size and stromal and adipocyte fractions were essentially pure ( > 99%).
Primary culture of preadipocytes Stromal cells isolated as above were suspended in Waymouth's medium (Gibco BRL Life Technologies, Gaithersburg, MD, USA) with 15% fetal calf serum (CSL, Parkville, Vic, Australia), plated into 35 mm dishes at a density of 1 or 2Â10 5 cells per dish and incubated at 37 C in a humidified atmosphere of 5% CO 2 in air until confluence. The cultured cells were then placed in Waymouth's serum-free medium for 36 h AE 1 mM dibutyryl cyclic AMP (db cAMP; Sigma, St Louis, MO, USA). Replicate dishes (three or four) were incubated with [4- 14 C]androstenedione (5 mM, 56 mCi=mmol; NEN Life Science, Boston, MA, USA) for 12 or 24 h. The media were collected and steroid metabolites analysed by thin layer chromatography (TLC). For each experiment, the protein content of one replicate dish was measured using the method of Bradford (Bio-Rad, Hercules, CA, USA). 
Thin layer chromatography

RNA extraction
Total RNA was extracted from adipose tissue using caesium chloride centrifugation 20 and RNA concentration and purity determined by measurement of absorbance at 260 and 280 nm. In addition, RNA samples were electrophoresed through ethidium bromide -stained agarose gels, visualised using FluorImager 595 Scanner (Molecular Dynamics) and the fluorescence of the 28S band was quantitated using ImageQuaNT software version 4.2a (Molecular Dynamics) to confirm equality of subcutaneous abdominal and omental RNA sample concentrations. Equality of RNA concentrations from preadipocyte and mature adipocyte fractions was confirmed similarly.
Localisation of type 3 17b-HSD expression
Reverse transcription of equal quantities of total RNA from preadipocyte and mature adipocyte fractions of omental adipose tissue from two women was carried out using random hexameric primers (Promega, Madison, WI, USA) with SuperScript II reverse transcriptase (Gibco BRL Life Technologies) under standard conditions. Total RNA from each cell fraction was incubated in the reverse transcription mix without the addition of reverse transcriptase for use as negative controls. Testis and placental RNA samples were included as positive controls for type 3 17b-HSD and aromatase, respectively. The cDNAs were amplified by PCR using oligonucleotide primers specific for b-actin (forward 5 Primer extension analysis of type 3 17b-HSD Primer extension analysis of total RNA from testis and female omental adipose tissue was carried out using standard methods. 20 The type 3 17b-HSD primer sequence was 5 0 GCCCTGTGAGGATGAAGAACTGTTC 3 0 , corresponding to nucleotides 64 to 88 of type 3 17b-HSD cDNA. 14 Primer extension for human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was carried out as a positive control using primer 5 0 TACGACCAAATCCGTTGACTCCGAC 3 0 which corresponds to nucleotides 76 -100 of the GAPDH cDNA. 21 The samples were electrophoresed through an 8% polyacrylamide gel containing 7 M urea and imaged using PhosphorImager scanning (Molecular Dynamics).
Establishment of quantitative multiplex competitive RT-PCR assay
In order to overcome the inherent variability in efficiency of reverse transcription and PCR amplification, mutant RNA transcripts prepared by in vitro transcription were used as competitive standards. Wild-type PCR products were quantitated using dilutions of known amounts of the mutant standards to determine the equivalence point of wild-type and mutant products. The cDNA of the entire coding region of type 3 17b-HSD (1153 bp, base pairs) 14 was subcloned into the HindIII and BamHI sites of pBluescript S=K (Stratagene, La Jolla, CA, USA; wild-type pBS17b-HSD-3; Figure 1 ). The 2.5 kb insert of human cytochrome P450 aromatase cDNA To prepare clones for in vitro transcription, wild-type and mutated clones for aromatase and for type 3 17b-HSD were linearised with PvuII and XbaI, respectively, and sense RNA transcripts were generated using a Riboprobe Kit (Promega) with T7 RNA polymerase. The reactions were heated at 65 C for 15 min, then incubated with 1 unit of RNase-free RQ1 DNase (Promega) for 30 min at 37 C, followed by extraction, precipitation and resuspension in DEPC-treated water. Before storage (770 C), the RNA concentration and purity were determined by measuring the absorbance at 260 and 280 nm. Using PCR primers as in 'Localisation of type 3 17b-HSD expression', it was predicted that there would be 11.1% difference in size of type 3 17b-HSD PCR products (380 bp wild-type, 342 bp mutant) and a 8.7% difference in size of aromatase PCR products (462 bp wild-type, 425 bp mutant).
Quantitative multiplex competitive RT-PCR assay of adipose tissue A series of two-fold dilutions of mutant RNAs for type 3 17b-HSD and aromatase in equimolar amounts was prepared in the same tubes, aliquoted and stored at 770 C. The same dilutions were used for all experiments and each aliquot was used only once. Subcutaneous and omental adipose RNA samples from each patient were analysed in the same assay. One set of reverse transcription reactions was set up for each wild-type RNA sample (0.25 mg=reaction) together with seven or eight dilutions of the mutant mRNA transcripts (range 5.1Â10 720 to 0.04Â10 720 mol). After the addition of random hexameric primers 0.125 mg (Promega), the reactions were incubated at 70 C for 10 min and then reverse transcription was carried out at 50 C for 50 min with SuperScript II reverse transcriptase according to the manufacturer's protocol Duplicate aliquots of the reverse transcription reaction were amplified by PCR in reactions containing primers for both type 3 17b-HSD and aromatase (primers and reaction conditions as in 'Localisation of type 3 17b-HSD expression'). Products were electrophoresed through non-denaturing 6% polyacrylamide gels, post-stained with SYBR Green I (Molecular Probes) and visualised with FluorImager 595 scanning (Molecular Dynamics). Bands were quantitated using ImageQuaNT software version 4.2a (Molecular Dynamics). Since the binding of nucleic acid stain is dependent on the size of the DNA molecule, a correction was made for the fluorescent density of the PCR products of different sizes by multiplying the fluorescent density of the mutant standard aromatase product by 1.087 and the mutant standard type 3 17b-HSD product by 1.111. The log of the ratio of corrected fluorescent densities of mutant standard product: wild-type product was plotted against the log of input mutant standard RNA (Â10 720 mol) using CA-Cricket Graph III software version 1.5.2. The amount of wild-type RNA was determined by extrapolating from the point on the line where the amount of amplified wild type and mutant standard products were equivalent (ie log 1 ¼ 0).
Statistical analysis
The 95% confidence intervals for the slopes of the plots of log (mutant standard fluorescent density=wild-type fluorescent density) against log mutant standard RNA were determined by regression analysis using Excel software version 7.0. Only experiments in which the 95% confidence intervals for the slope of the regression line included 1.0, indicating that the wild-type and mutant transcripts were amplified with equal efficiency, were analysed further. Correlations between patient parameters and adipose tissue expression of type 3 17b-HSD and aromatase were analysed using Pearson's correlation coefficient, r, calculated using CACricket Graph III software version 1.5.2. The statistical significance of the correlations was based on the 5% two-tailed significance levels of r. Messenger RNA levels for type 3 17b-HSD and aromatase were compared using one way analysis of variance (ANOVA) with post-hoc Student's t-test for paired samples.
Results
Localisation of type 3 17b-HSD expression in adipose tissue Reverse transcription was successful in both the preadipocyte and adipocyte RNA samples from two patients, as shown by a product of expected size on amplification using primers for b-actin (213 bp, Figure 2 ). Using primers for aromatase and type 3 17b-HSD, products of predicted size for aromatase (462 bp) and type 3 17b-HSD (380 bp) were detected only in the preadipocyte fraction (Figure 2 ).
Primer extension analysis of type 3 17b-HSD in adipose tissue and testis Primer extension analysis using a primer for GAPDH confirmed that RNA from these tissues was of sufficient quality for these analyses (results not shown). A major primer extension product of approximately 330 nucleotides was detected for type 3 17b-HSD in both the omental adipose tissue and testis samples (Figure 3) .
In vitro preadipocyte steroidogenesis
Under basal conditions, cultured preadipocytes from subcutaneous abdominal and intra-abdominal sites converted androstenedione to testosterone, and to a lesser extent, to dihydrotestosterone. The conversion rate of androstenedione to testosterone was similar for preadipocytes from both sites (0.23 AE 0.04 nmol=100 mg protein=12 h subcutaneous, 0.17 AE 0.01 nmol=100 mg protein=12 h intra-abdominal, mean AE s.e.m.). Whilst dibutyryl cAMP stimulated this conversion, this achieved statistical significance only for the intra-abdominal preadipocytes (Figure 4) . Conversion of androstenedione to estrone under basal conditions was negligible in preadipocytes from both sites. Following incubation with dibutyryl cAMP, conversion of androstenedione to estrone was detected in only three of the 10 primary cultures (two subcutaneous abdominal and one intra-abdominal preadipocytes). However, in these three preadipocyte cultures, the conversion of androstenedione to estrone was small relative to their conversion of androstenedione to testosterone (14, 42 and 22% of conversion to testosterone, respectively). Conversion of androstenedione to estradiol, which requires the activity of both 17b-HSD and aromatase and therefore cannot be used as an indication of the activity of either enzyme in isolation, was just detectable at baseline in only two cultures, both intra-abdominal preadipocytes.
Validation of the quantitative multiplex competitive RT-PCR assay
Heteroduplex formation was noted in this assay. To ensure that this did not effect quantitation, known amounts of wild-type RNA transcripts for both type 3 17b-HSD and aromatase were assayed using the multiplex competitive RT-PCR assay. The estimates from the assay were linearly related to the amount of input wild-type RNA. The assay underestimated, on average, the levels of both RNA transcripts by about 35% (data not shown). Thus heteroduplex formation did not effect the estimates of the relative levels of each mRNA. No corrections have been applied to our data as presented below.
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We carried out the multiplex competitive RT-PCR assay using total RNA from placenta and testis, tissues which are known to have high levels of expression of aromatase and type 3 17b-HSD, respectively, and the results were as expected. The placenta had > 510Â10 720 mol of aromatase mRNA per 0.25 mg total RNA and no measurable type 3 17b-HSD mRNA, whereas the testis had approximately 40Â10 720 and 1.3Â10 720 mol per 0.25 mg total RNA of type 3 17b-HSD and aromatase mRNA, respectively.
To demonstrate that the results of the assay were reproducible, one sample of intra-abdominal adipose tissue RNA was reverse transcribed along with two dilutions of mutant standard RNAs, in four separate reactions. Aliquots (four) of each reaction were then amplified using PCR. With only two data points, the inter-assay coefficient of variation was low at 7.5, 25 and 19% for type 3 17b-HSD mRNA, aromatase mRNA and the ratio of type 3 17b-HSD to aromatase mRNA, respectively. For the competitive RT-PCR assays of adipose tissue samples Figure 2 RT-PCR analyses of expression of type 3 17b-HSD and aromatase in preadipocytes and adipocytes. RT-PCR of the preadipocyte and adipocyte fractions (RT) of patient no. 1 using primers specific for type 3 17b-HSD and b-actin. RT-PCR of the preadipocyte and adipocyte fractions of patient no. 2 (RT), testis (T) and placenta (P) and no RNA (N) using primers specific for aromatase, type 3 17b-HSD and b-actin. Non-reverse-transcribed controls (non-RT) were included for adipocyte and preadipocyte RNA. The gels are 2% agarose, stained with ethidium bromide and imaged using the FluorImager 595. The molecular weight markers (M) are HpaII-digested pUC19 and the product sizes (bp) are arrowed.
Type 3 17b-HSD and aromatase in adipose tissue AM Corbould et al described below, seven or eight two-fold dilutions of mutant standard RNA were used for quantitation.
Type 3 17-HSD and aromatase mRNA levels
The yield of total RNA (mean AE s.e.m.) was significantly greater from intra-abdominal adipose tissue than from subcutaneous abdominal adipose tissue of the same patient: 11.6 AE 3.5 mg total RNA=g intra-abdominal adipose tissue, compared with 2.1 AE 0.4 mg total RNA=g subcutaneous adipose tissue (P < 0.05; n ¼ 10). An example of the competitive RT-PCR analysis of one patient is shown in Figure 5 . The levels of aromatase mRNA in both subcutaneous abdominal (n ¼ 8) and intraabdominal (n ¼ 12) adipose tissue samples were variable between patients (range 0.05 -0.63 and 0.02 -1.19Â 10 720 mol mRNA=0.25 mg total RNA, respectively), but the mean levels were similar between these two deposits. The concentrations of type 3 17b-HSD mRNA were similarly variable between patients (range 0.11 -2.50 and 0.09 -2.10Â10 720 mol mRNA=0.25 mg total RNA in subcutaneous abdominal (n ¼ 10) and intra-abdominal (n ¼ 15) adipose tissue samples, respectively), but mean levels were also similar between these two deposits. Despite these large variations, where both type 3 17b-HSD and aromatase mRNA levels were available in the same adipose tissue deposit, the levels of type 3 17b-HSD mRNA were 2 -3-fold higher than aromatase mRNA at both the subcutaneous abdominal and intra-abdominal sites (P < 0.05, ANOVA and post hoc t-test for paired samples). In subcutaneous abdominal adipose tissue samples (n ¼ 8), the type 3 17b-HSD and aromatase mRNA concentrations were 1.11 AE 0.30 and 0.32 AE 0.08Â10 720 mol mRNA=0.25 mg total RNA (meanAE s.e.m.), respectively. In intra-abdominal adipose tissue samples (n ¼ 12), the type 3 17b-HSD and aromatase mRNA concentrations were 0.95 AE 0.21 and 0.36 AE 0.10Â10 720 mol mRNA=0.25 mg total RNA (mean AE s.e.m.), respectively.
The ratio of the levels of type 3 17b-HSD mRNA to aromatase mRNA in subcutaneous abdominal adipose tissue ranged from 1.0 to 8.4 (3.7 AE 2.5, mean AE s.d.), and in intra-abdominal adipose tissue 0.8 to 6.0 (3.4 AE 1.6, mean AE s.d.). With increasing BMI, there was an increase in the ratio of the levels of type 3 17b-HSD mRNA to aromatase mRNA in intra-abdominal adipose tissue ( Figure 6 ; r ¼ þ 0.61, n ¼ 11; P < 0.05). This was mostly due to a decrease in aromatase expression: the correlation with BMI of type 3 17b-HSD and aromatase mRNA levels in intraabdominal adipose tissue was 7 0.14 and 7 0.40, respectively. Conversely, in subcutaneous adipose tissue the ratio of type 3 17b-HSD mRNA to aromatase mRNA was negatively correlated with BMI ( Figure 6 ; r ¼ 7 0.71, n ¼ 7; NS). This was due mainly to a decrease in type 3 17b-HSD expression: the correlation with BMI of type 3 17b-HSD and aromatase mRNA levels in subcutaneous adipose tissue was 7 0.58 and 7 0.15, respectively. Correlations with waist Figure 3 Primer extension analysis of type 3 17b-HSD in female omental adipose tissue and testis. Molecular weight markers are radiolabeled HpaII-digested pUC19. The major primer extended product is arrowed. Figure 4 Effect of dibutyryl cAMP on the conversion of androstenedione to testosterone in cultured subcutaneous and intra-abdominal preadipocytes of women (n ¼ 5). Preadipocytes were cultured to confluence and incubated in serum-free medium without (control) and with 1 mM dibutyryl cAMP (db cAMP), followed by a further 12 or 24 h incubation with addition of 5 mM 4-14 C-androstenedione. In intraabdominal preadipocytes, db cAMP resulted in a significant increase in conversion of androstenedione to testosterone (P < 0.05; ANOVA with post hoc Student -Newman -Keuls test). (Figure 6 ). Statistical analysis did not reveal any significant correlation between the 17b-HSD : aromatase ratio and either reproductive status of the women (pre-or post-menopausal) or age.
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AM Corbould et al circumference were similar
Discussion
These studies have shown for the first time that both type 3 17b-HSD and aromatase are expressed in the preadipocyte fraction of adipose tissue and not in mature adipocytes. This is in agreement with previous reports that the stromal fraction accounts for 87% of aromatase activity 5 and that aromatase mRNA concentration is 4-fold greater in adipose stromal cells compared to adipocytes. 23 The coexistence of type 3 17b-HSD and aromatase in preadipocytes predicts the conversion of their common substrate, androstenedione, to both testosterone and estrone. Our in vitro studies have confirmed this and have demonstrated that, in both subcutaneous abdominal and intra-abdominal adipose tissue, there is substantially more conversion of androstenedione to testosterone than to estrone. Culture of preadipocytes with dibutyryl cAMP Figure 5 Multiplex competitive RT-PCR assay for quantitation of type 3 17b-HSD and aromatase expression in subcutaneous abdominal adipose tissue. Intra-abdominal samples from the subject were analysed in the same assay (not shown). Duplicate aliquots of reverse-transcription reactions of subcutaneous abdominal adipose tissue (A, B) amplified by PCR using primers for both aromatase and type 3 17b-HSD. Negative controls (N) were wild-type RNA plus mutant RNA transcripts incubated in the reverse-transcription mix without the addition of reverse transcriptase. Regression lines of log (mutant standard fluorescent density=wild-type fluorescent density) against log (input mutant standard RNA) were plotted (C, D). The amount of wild-type mRNA (10 720 mol=0.25 mg total RNA) was determined by extrapolating from the point on the line where the amount of amplified mutant standard and wildtype products were equivalent, ie at log 1 ¼ 0. A, B are non-denaturing 6% polyacrylamide gels, stained with SYBR Green I and imaged using the Fluorlmager 595. The sizes of the products (bp) are indicated.
Type 3 17b-HSD and aromatase in adipose tissue AM Corbould et al augmented this difference and confirmed that cyclic AMPdependent mechanisms exist in preadipocytes to mediate the regulation of type 3 17b-HSD, as is the case for aromatase. 24 Unlike aromatase which utilises tissue-specific promoters, 9 the transcription start site for type 3 17b-HSD is the same in adipose tissue and testis.
Simultaneous measurements of mRNA levels of type 3 17b-HSD and aromatase in subcutaneous abdominal and intra-abdominal adipose deposits of women were made using a multiplex competitive RT-PCR assay. This provided further support for the in vitro findings by showing that tissue levels of type 3 17b-HSD mRNA were on average three times greater than aromatase. Large between-subject variability in mRNA levels of the two enzymes was observed. Similar variability in aromatase mRNA levels has been described previously by Bulun and Simpson, 8 who found a 40-fold difference in aromatase expression in subcutaneous abdominal adipose tissue of women.
An important additional observation of our studies was the finding that generalised obesity (as indicated by BMI) or central obesity (as judged by waist circumference) was correlated with the ratio of type 3 17b-HSD: aromatase mRNA. Furthermore, this effect differed in adipose tissue derived from subcutaneous abdominal and intra-abdominal sites. In general, with increasing obesity, there was a decrease in type 3 17b-HSD expression and a fall in the type 3 17b-HSD mRNA:aromatase mRNA ratio in subcutaneous abdominal adipose tissue, whilst in intra-abdominal adipose tissue there was a tendency for aromatase levels to decline with obesity resulting in an increase in type 3 17b-HSD mRNA:aromatase mRNA ratio. If these changes in mRNA expression are reflected in enzyme activity for type 3 17b-HSD and aromatase, this would predict that obesity is associated with a decline in androgen production in subcutaneous abdominal adipose tissue and a relatively greater androgen production in intra-abdominal adipose tissue of women. The physiological mechanism which causes variation in the expression of type 3 17b-HSD and aromatase in different adipose tissue deposits with obesity remains to be explored. Local factors in adipose tissue, especially cytokines and growth factors, may regulate the expression of type 3 17b-HSD, as has been shown for aromatase. 9 Although the levels of type 3 17b-HSD mRNA were similar in subcutaneous and intra-abdominal adipose tissue, it is important to recognise that the levels were expressed in terms of total RNA and not per unit weight of adipose tissue. For reasons that are not apparent, the yield of total RNA per gram of intra-abdominal adipose tissue was much greater than from subcutaneous adipose tissue, and hence the overall tissue expression of type 3 17b-HSD is higher in intraabdominal adipose tissue than in subcutaneous abdominal adipose tissue. The important contribution of subcutaneous Figure 6 The ratio of type 3 17b-HSD mRNA to aromatase mRNA in the subcutaneous abdominal and intra-abdominal adipose tissue of women vs their BMI or waist circumference. The formula for the line of best fit and the correlation coefficient, r, are also presented. The correlation of the ratio of type 3 17b-HSD to aromatase mRNA in intra-abdominal adipose tissue with BMI and waist circumference is significant (P < 0.05).
Type 3 17b-HSD and aromatase in adipose tissue AM Corbould et al adipose tissue and other peripheral tissues to the overall circulating level of sex steroids is widely accepted, 1,2 but the impact of testosterone production by intra-abdominal tissues is largely unrecognised because of the efficiency of hepatic clearance. 1, 25 Nonetheless, given that in obese women the amount of intra-abdominal adipose tissue may increase 10-fold 26 with a proportional increase in the numbers of both preadipocytes and adipocytes 27 and the ratio of type 3 17b-HSD to aromatase mRNA in intra-abdominal adipose tissue may be as high as 6, there is potential for substantial production of testosterone in this adipose tissue deposit.
Increased testosterone production in intra-abdominal adipose tissue could have important metabolic consequences either locally, or via direct drainage through the portal venous system, on the liver. High affinity androgen binding sites have been identified in human adipose tissue 28, 29 and androgen receptor mRNA has been shown to be present in human preadipocytes and mature adipocytes. 29 High affinity androgen binding sites and androgen receptor protein have been identified in the normal hepatic tissue of a proportion of women. 30, 31 The presence of androgen receptors in these tissues confirms that they are potential targets for androgen action.
It has been demonstrated that b-adrenergic receptor activity in intra-abdominal adipose tissue of obese women is higher than in lean women, leading to increased lipolysis and release of free fatty acids. 32 Testosterone may mediate this effect because it has been shown to increase adipocyte badrenergic receptor expression. 33, 34 Increased delivery of free fatty acids to the liver has been implicated in the reduced insulin clearance and dyslipidaemia associated with central obesity. 35 In summary, these studies have suggested that adipose tissue from the subcutaneous abdominal and intra-abdominal sites of women has different steroidogenic potentials which may be influenced by body weight. The expression of type 3 17b-HSD is generally greater than aromatase in both the subcutaneous abdominal and intra-abdominal adipose tissue of women. The data presented here suggest that as the amount of adipose tissue increases in women, either overall obesity or central obesity, subcutaneous abdominal adipose tissue becomes potentially less androgenic due to a fall in the expression of type 3 17b-HSD mRNA, while intra-abdominal adipose tissue becomes potentially more androgenic due to a fall in the expression of aromatase mRNA. We postulate that increased androgenicity of the intra-abdominal adipose tissue deposit with obesity in women may influence lipid turnover in this tissue, with adverse consequences for hepatic insulin and lipid metabolism. Exposure of the liver to excess androgens from local production in intra-abdominal adipose tissue may also have important adverse effects.
